In human GBM, positive HIF1α expression was correlated to a dismal prognosis, the overexpression was associated with unsatisfactory therapeutic response and resistance to radiotherapy and chemotherapy, while the negative expression predicted better outcomes [264]. Here, HIF1A is linked to glioblastoma.